Treats vitamin A deficiency. Sold as Aquasol A. Every FDA application for this active ingredient: 1 branded and 24 generic.
As of Nov 16, 2026, FDA lists 25 applications for Vitamin A Palmitate (sold as Aquasol A), first approved May 18, 1949, with 0 new uses approved and 0 published complete response letters.
| Salicylic Acid Solution Versus Tretinoin 0.05% Cream for Treating Plane WartsPlane Warts · Combined Military Hospital, Pakistan | Not applicable | Not yet recruiting | Nov 10, 2026 |
| Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaAcute Myeloblastic Leukemia · Second Affiliated Hospital of Nanchang University | Phase 1 / Phase 2 | Not yet recruiting | Nov 9, 2026 |
| Maltodextrin Versus Sugar Water Carbohydrate Loading and Gastric Volume in Geriatric Lower Limb Orthopedic SurgeryRespiratory Aspiration, Hyperglycemia · Udayana University | Not applicable | Recruiting | Oct 14, 2026 |
| Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of EpendymomaChildhood Posterior Fossa Ependymoma · Children's Oncology Group | Phase 1 / Phase 2 | Not yet recruiting | Sep 30, 2026 |
| Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceEGFR-TKI-resistant Non-Small Cell Lung Cancer · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 1 | Not yet recruiting | Sep 25, 2026 |
| Vitamin A Supplementation and Breast Milk Vitamin A Levels in Mothers of Preterm InfantsPremature, Preterm Infant Health · University of Mississippi Medical Center | Not applicable | Not yet recruiting | Jul 30, 2026 |
| Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in MelasmaMelasma, Melasma (Facial Melasma) · Combined Military Hospital Abbottabad | Phase 4 | Not yet recruiting | Jul 28, 2026 |
| Immune-Mitochondrial Correction in Military RecruitsRespiratory Tract Infections (RTI), Meningitis · MIPO Clinic | Not applicable | Not yet recruiting | Jun 2, 2026 |
| May 18, 1949 | Aquasol ANDA 6823 | Casper Pharma LLC | 13 | Marketed |
| Nov 17, 1972 | AfaxinANDA 83187 | Sterling Winthrop | 0 | Discontinued |
| Dec 19, 1972 | Vitamin AANDA 83190 | Ivax Sub Teva Pharms | 1 | Discontinued |
| Dec 20, 1972 | Vitamin AANDA 83035 | Ivax Sub Teva Pharms | 1 | Discontinued |
| Mar 14, 1973 | Vi-Dom-AANDA 80972 | Bayer Pharms | 0 | Discontinued |
| May 2, 1973 | Vitamin AANDA 83457 | Mk Labs | 0 | Discontinued |
| May 4, 1973 | Vitamin AANDA 80967 | West Ward | 0 | Discontinued |
| Jul 18, 1973 | AlphalinANDA 80883 | Lilly | 0 | Discontinued |
| Aug 1, 1973 | Vitamin AANDA 80953 | Impax Labs | 1 | Discontinued |
| Aug 2, 1973 | Vitamin AANDA 80955 | Impax Labs | 2 | Discontinued |
| Nov 13, 1973 | Vitamin AANDA 83665 | Wharton Labs | 0 | Discontinued |
| Mar 6, 1974 | Vitamin A PalmitateANDA 80819 | Bel Mar | 0 | Discontinued |
| Jun 10, 1974 | Vitamin A PalmitateANDA 83948 | Banner Pharmacaps | 2 | Discontinued |
| Jun 19, 1980 | Vitamin AANDA 80702 | Banner Pharmacaps | 3 | Discontinued |
| — | Vitamin AANDA 80746 | Chase Chem | 0 | Discontinued |
| — | Del-Vi-AANDA 80830 | Del Ray Labs | 0 | Discontinued |
| — | Vitamin AANDA 80860 | Bristol Myers Squibb | 0 | Discontinued |
| — | Vitamin A SolubilizedANDA 80921 | Teva | 0 | Discontinued |
| — | Vitamin AANDA 80943 | Everylife | 0 | Discontinued |
| — | Vitamin AANDA 83114 | Everylife | 0 | Discontinued |
| — | Vitamin AANDA 83207 | Chase Chem | 0 | Discontinued |
| — | Vitamin A PalmitateANDA 83311 | Arcum | 0 | Discontinued |
| — | Vitamin A PalmitateANDA 83321 | Arcum | 0 | Discontinued |
| — | Vitamin A PalmitateANDA 83981 | Banner Pharmacaps | 0 | Discontinued |
| — | Vitamin AANDA 85479 | Elkins Sinn | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA